A

ADC Therapeutics SA

D
ADCT
USD
-0.17
(-6.0284%)
Market Closed
8,554.00
حجم التداول
-1.59
الربح لكل سهم
-
العائد الربحي
-1.043307
P/E
256,222,428.85
حجم السوق
اليوم
-6.0284%
1 اسبوع
-9.247%
1 شهر
-13.257%
6 اشهر
-33.584%
12 اشهر
381.818%
بداية السنة
58.683%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
ADC Therapeutics SA

Sector:
Healthcare
Industry:
Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
هل تحتاج مساعدة او لديك استفسار؟